Acute myeloid leukemia (AML), the most common form of acute leukemia, is characterized by an increase of malignant myeloid progenitor cells at the expense of mature blood cells. Only twenty-...
Treating recurrent acute myeloid leukemia (AML), an aggressive blood cancer that is one of the most lethal diseases, has become difficult. About 19,520 news cases are diagnosed a year, and a...
Newer targeted drug ibrutinib was more effective than standard therapy for treating elderly patients with chronic lymphocytic leukemia (CLL), found landmark study co-authored by a Loyola Med...
An active ingredient in eye drops was found to show promising results in treating an aggressive form of blood cancer, said scientists at the Wellcome Sanger Institute, University of Cambridg...
In mice, two successful treatments slowed the progression of pediatric leukemia, according to three studies published over the last two years in the journal Cell, and the final paper publish...
A combination of ibrutinib, a targeted treatment already in clinical use, with a new inhibitor called AZD8055 can help treat hard to treat cases of chronic lymphocytic leukemia (CLL). T...
Rapid drug response screening for leukemia stem cells offers clues to relapse and to improving patient-specific therapies, revealed research. AML is a serious disorder of certain blo...
Combination of ibrutinib plus rituximab was found superior to the old treatment for patients aged below 70 years with chronic lymphocytic leukemia (CLL) who are previously untreated, accordi...
Xospata, the new drug, has been approved recently by the US Food and Drug Administration (FDA) for treating adults with relapsed or refractory acute myeloid leukemia (AML) having the FLT3 mu...
Venetoclax with azacitidine combination shown 91 percent response rate among older adults who were newly diagnosed with acute myeloid leukemia (AML), according to a study published in Natur...
A promising strategy to treat chemotherapy-resistant acute myeloid leukemia has been developed by a team of researchers from The Ottawa Hospital and the University of Ottawa. In a mouse...
High amount of stress in patients with chronic lymphocytic leukemia (CLL) is associated with more cancer cells in their blood and raised levels of three different markers of more advanced il...
LEDGF/p75 protein is regulated by phosphorylation, a molecular modification that changes the electrical charge of the LEDGF/p75 protein in children with mixed lineage leukemia, found researc...
A large group of patients with chronic lymphocytic leukemia were found to have a sizable 600 percent higher risk of melanoma, the most dangerous form of skin cancer. A Wilmot Cancer Institu...
NPM1 mutation improves sensitivity to chemotherapy in patients with leukemia, stated study published in journal JCI Insight. Previous research has revealed that patients with acute m...
Acute myeloid Leukemia, more popularly known by its abbreviated form AML, is a fast- evolving leukemia that affects both children and adults alike
Blood Cancer Overview Blood cancer or hematological cancer is cancer affecting the normal production and function of the various blood cells. Take this quiz and learn about the various types of blood ...
Childhood or pediatric cancers occur in children less than 15 years of age. They are rare and differ from adult tumors in their location and behaviour.
Hairy cell leukemia (HCL) is a type of leukemia where there are increased numbers of abnormal B-lymphocytes, a type of white blood cells.
'Chemo' means medicine or 'drug'; 'therapy' means 'treatment'. Chemotherapy refers to the use of cytotoxic drugs in cancer treatment.
Chronic Lymphocytic Leukemia (CLL) is one of the most common types of adult leukemia and is considered as one of the 'good cancers'.
Chronic myeloid Leukemia is one of the most common types of blood cancer. It is characterized by excess of WBC stem cells in the bone marrow.
Encyclopedia section of medindia gives general information about Leukemia
Non Hodgkins Lymphoma is a cancer that affects the lymph tissues. It is made up of a wide array of subtypes.
Acute lymphoblastic leukemia (ALL) is the cancer of white blood cells characterized by excess lymphoblasts. It is the most common of all childhood cancers and can be fatal in weeks if left untreated.
Show More Related Topics
Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.